Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 5:36 PM View:  | Tahir Misbah Chief Financial Officer | Igm Biosciences, Inc. (IGMS) | 18-Nov-24 | Grant | 66,667 | -- | -- | 54% 122.69K to 189.36K | |
| 04-Oct-24 6:23 PM View: | Harler Mary Beth Chief Executive Officer Director | Igm Biosciences, Inc. (IGMS) | 02-Oct-24 | Grant | 185,000 | -- | -- | 113% 163.74K to 348.74K | |
| 17-Sep-24 8:50 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 13-Sep-24 | Sale | 1,487 | $11.54 | $17,158.20 | (< 1%) 248.47K to 246.99K | |
| 17-Sep-24 8:42 PM View: | Decker Lisa Lynn Chief Business Officer | Igm Biosciences, Inc. (IGMS) | 13-Sep-24 | Sale | 925 | $11.54 | $10,673.40 | (1%) 80.03K to 79.1K | |
| 17-Sep-24 8:44 PM View: | Harler Mary Beth Head, Research & Autoimmunity | Igm Biosciences, Inc. (IGMS) | 13-Sep-24 | Sale | 1,487 | $11.54 | $17,158.20 | (< 1%) 165.23K to 163.74K | |
| 17-Sep-24 8:52 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 13-Sep-24 | Sale | 3,946 | $11.54 | $45,532.10 | (< 1%) 450.79K to 446.84K | |
| 17-Sep-24 8:58 PM View: | Weber Steven Principal Accounting Officer | Igm Biosciences, Inc. (IGMS) | 13-Sep-24 | Sale | 469 | $11.54 | $5,411.70 | (2%) 26.01K to 25.54K | |
| 17-Sep-24 8:54 PM View: | Tahir Misbah Chief Financial Officer | Igm Biosciences, Inc. (IGMS) | 13-Sep-24 | Sale | 1,487 | $11.54 | $17,158.20 | (1%) 124.18K to 122.69K | |
| 17-Sep-24 8:55 PM View: | Takimoto Chris H Chief Medical Officer | Igm Biosciences, Inc. (IGMS) | 13-Sep-24 | Sale | 1,487 | $11.54 | $17,158.20 | (< 1%) 155.82K to 154.33K | |
| 12-Aug-24 8:30 PM View: | Strohl William Director | Igm Biosciences, Inc. (IGMS) | 08-Aug-24 | Grant | 125,000 | -- | -- | 100% 0 to 125.0K | |
| 29-Jul-24 5:45 PM View: | Hambleton Julie Director | Igm Biosciences, Inc. (IGMS) | 25-Jul-24 | Option Exercise | 15,132 | $1.39 | $21,033.50 | 757% 2.0K to 17.13K | |
| 29-Jul-24 5:45 PM View: | Hambleton Julie Director | Igm Biosciences, Inc. (IGMS) | 25-Jul-24 | Planned Option Sale | 15,132 | $14.00 | $211,848.00 | (88%) 17.13K to 2.0K | |
| 23-Jul-24 8:42 PM View: | Tahir Misbah Chief Financial Officer | Igm Biosciences, Inc. (IGMS) | 19-Jul-24 | Grant | 35,333 | -- | -- | 40% 88.85K to 124.18K | |
| 23-Jul-24 8:44 PM View: | Takimoto Chris H Chief Medical Officer | Igm Biosciences, Inc. (IGMS) | 19-Jul-24 | Grant | 60,000 | -- | -- | 63% 95.82K to 155.82K | |
| 23-Jul-24 8:40 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 19-Jul-24 | Grant | 46,666 | -- | -- | 23% 201.81K to 248.47K | |
| 23-Jul-24 8:36 PM View: | Decker Lisa Lynn Chief Business Officer | Igm Biosciences, Inc. (IGMS) | 19-Jul-24 | Grant | 20,000 | -- | -- | 33% 60.03K to 80.03K | |
| 23-Jul-24 8:38 PM View: | Harler Mary Beth Head, Research & Autoimmunity | Igm Biosciences, Inc. (IGMS) | 19-Jul-24 | Grant | 80,000 | -- | -- | 94% 85.23K to 165.23K | |
| 02-Jul-24 9:30 PM View: | Lee Michael Stewart Director | Igm Biosciences, Inc. (IGMS) | 28-Jun-24 | Grant | 1,734 | -- | -- | 30% 5.85K to 7.59K | |
| 02-Jul-24 8:07 PM View: | Thompson Elizabeth H.Z. Director | Igm Biosciences, Inc. (IGMS) | 28-Jun-24 | Grant | 1,452 | -- | -- | 100% 1.45K to 2.9K | |
| 02-Jul-24 8:06 PM View: | Behrens M Kathleen Director | Igm Biosciences, Inc. (IGMS) | 28-Jun-24 | Grant | 3,078 | -- | -- | < 1% 400.36K to 403.44K | |
| 02-Jul-24 9:30 PM View: | Redmile Group, LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 28-Jun-24 | Grant Duplicate | 1,734 | -- | -- | < 1% 3.08M to 3.08M | |
| 02-Jul-24 8:09 PM View: | Topsoe Jakob Haldor Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 28-Jun-24 | Grant | 1,734 | -- | -- | < 1% 10.49M to 10.49M | |
| 02-Jul-24 8:08 PM View: | Topsoe Christina Teng Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 28-Jun-24 | Grant | 2,687 | -- | -- | < 1% 10.45M to 10.46M | |
| 18-Jun-24 7:40 PM View: | Harler Mary Beth Head, Research & Autoimmunity | Igm Biosciences, Inc. (IGMS) | 14-Jun-24 | Sale | 1,570 | $7.58 | $11,893.20 | (2%) 86.8K to 85.23K | |
| 18-Jun-24 7:42 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 14-Jun-24 | Sale | 4,164 | $7.58 | $31,543.60 | (< 1%) 454.95K to 450.79K | |
| 18-Jun-24 7:45 PM View: | Weber Steven Principal Accounting Officer | Igm Biosciences, Inc. (IGMS) | 14-Jun-24 | Sale | 495 | $7.58 | $3,749.77 | (2%) 26.51K to 26.01K | |
| 18-Jun-24 7:43 PM View: | Tahir Misbah Chief Financial Officer | Igm Biosciences, Inc. (IGMS) | 14-Jun-24 | Sale | 1,570 | $7.58 | $11,893.20 | (2%) 90.42K to 88.85K | |
| 18-Jun-24 7:44 PM View: | Takimoto Chris H Chief Medical Officer | Igm Biosciences, Inc. (IGMS) | 14-Jun-24 | Sale | 1,570 | $7.58 | $11,893.20 | (2%) 97.39K to 95.82K | |
| 18-Jun-24 7:41 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 14-Jun-24 | Sale | 1,106 | $7.58 | $8,378.28 | (< 1%) 202.91K to 201.81K | |
| 18-Jun-24 7:38 PM View: | Decker Lisa Lynn Chief Business Officer | Igm Biosciences, Inc. (IGMS) | 14-Jun-24 | Sale | 977 | $7.58 | $7,401.07 | (2%) 61.01K to 60.03K | |
| 18-Jun-24 7:41 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 15-May-24 | Grant | 3,000 | $5.02 | $15,060.00 | 2% 199.91K to 202.91K | |
| 18-Jun-24 7:42 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 15-May-24 | Grant | 3,000 | $5.02 | $15,060.00 | < 1% 451.95K to 454.95K | |
| 18-Jun-24 7:44 PM View: | Takimoto Chris H Chief Medical Officer | Igm Biosciences, Inc. (IGMS) | 15-May-24 | Grant | 3,000 | $5.02 | $15,060.00 | 3% 94.39K to 97.39K | |
| 02-Apr-24 6:29 PM View: | Topsoe Jakob Haldor Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 1,734 | -- | -- | < 1% 10.48M to 10.49M | |
| 01-Apr-24 9:30 PM View: | Redmile Group, LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant Duplicate | 1,734 | -- | -- | < 1% 6.15M to 6.15M | |
| 02-Apr-24 6:27 PM View: | Topsoe Christina Teng Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 2,687 | -- | -- | < 1% 10.45M to 10.45M | |
| 02-Apr-24 7:18 PM View: | Lee Michael Stewart Director | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 1,734 | -- | -- | 42% 4.12K to 5.85K | |
| 02-Apr-24 6:25 PM View: | Thompson Elizabeth H.Z. Director | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 1,452 | -- | -- | 100% 0 to 1.45K | |
| 01-Apr-24 4:22 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 3,988 | -- | -- | < 1% 4.1M to 4.1M | |
| 02-Apr-24 6:22 PM View: | Behrens M Kathleen Director | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant | 3,078 | -- | -- | < 1% 397.28K to 400.36K | |
| 28-Mar-24 7:04 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 28-Mar-24 | Purchase | 97,473 | $9.62 | $937,632.00 | 2% 4.0M to 4.1M | |
| 01-Apr-24 9:30 PM View: | Redmile Group, LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 28-Mar-24 | Disposition (other) | 12,464 | -- | -- | (< 1%) 6.17M to 6.15M | |
| 28-Mar-24 7:04 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 27-Mar-24 | Purchase | 27,844 | $9.24 | $257,170.00 | < 1% 3.98M to 4.0M | |
| 28-Mar-24 7:22 PM View: | Keyt Bruce Chief Scientific Officer | Igm Biosciences, Inc. (IGMS) | 26-Mar-24 | Grant | 24,019 | -- | -- | 14% 175.9K to 199.91K | |
| 28-Mar-24 7:24 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 26-Mar-24 | Grant | 38,583 | -- | -- | 9% 413.37K to 451.95K | |
| 28-Mar-24 7:04 PM View: | Baker Bros Advisors LLC Director 10% Owner | Igm Biosciences, Inc. (IGMS) | 26-Mar-24 | Private Purchase | 270,000 | $8.26 | $2,230,770.00 | 7% 3.71M to 3.98M | |
| 15-Mar-24 7:57 PM View: | Weber Steven Principal Accounting Officer | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 464 | $10.17 | $4,719.11 | (2%) 26.97K to 26.51K | |
| 15-Mar-24 7:48 PM View: | Decker Lisa Lynn Chief Business Officer | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 1,578 | $10.17 | $16,049.00 | (3%) 62.58K to 61.01K | |
| 15-Mar-24 7:51 PM View: | Schwarzer Fred CEO and President Director | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 4,182 | $10.17 | $42,533.00 | (1%) 417.55K to 413.37K | |
| 15-Mar-24 7:55 PM View: | Takimoto Chris H Chief Medical Officer | Igm Biosciences, Inc. (IGMS) | 14-Mar-24 | Sale | 2,535 | $10.17 | $25,782.20 | (3%) 96.92K to 94.39K |
